
electroCore ECOR
€ 5.25
1.32%
Geschäftsbericht 2025
hinzugefügt 19.03.2026
electroCore Langfristiger Schuldenstrom 2011-2026 | ECOR
Langfristiger Schuldenstrom Jährlich electroCore
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 375 K | 361 K | 89 K | 74 K | 61 K | 535 K | 486 K | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 535 K | 61 K | 283 K |
Langfristiger Schuldenstrom anderer Aktien in der Medizinische Instrumente
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Alcon
ALC
|
80 M | $ 75.4 | -0.8 % | $ 40.4 B | ||
|
Ekso Bionics Holdings
EKSO
|
441 K | $ 11.21 | -1.41 % | $ 27.2 M | ||
|
The Cooper Companies
COO
|
37.8 M | $ 63.09 | -1.94 % | $ 12.6 B | ||
|
ICU Medical
ICUI
|
13.8 M | $ 121.01 | -1.5 % | $ 2.98 B | ||
|
iRhythm Technologies
IRTC
|
16.7 M | $ 125.44 | -0.41 % | $ 4.01 B | ||
|
Haemonetics Corporation
HAE
|
8.11 M | $ 59.84 | -1.06 % | $ 3.01 B | ||
|
Repro Med Systems
KRMD
|
413 K | $ 4.08 | 0.49 % | $ 188 M | ||
|
Isoray
ISR
|
623 K | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
39 M | $ 466.64 | -0.92 % | $ 167 B | ||
|
Microbot Medical
MBOT
|
296 K | $ 2.1 | -3.23 % | $ 96.2 M | ||
|
Glaukos Corporation
GKOS
|
1.31 M | $ 119.63 | -2.0 % | $ 5.79 B | ||
|
Milestone Scientific
MLSS
|
130 K | $ 0.33 | -4.15 % | $ 27.1 M | ||
|
Masimo Corporation
MASI
|
21.4 M | $ 178.51 | -0.08 % | $ 9.51 B | ||
|
InfuSystem Holdings
INFU
|
349 K | $ 10.18 | -4.5 % | $ 210 M | ||
|
Merit Medical Systems
MMSI
|
10.9 M | $ 66.74 | -1.02 % | $ 3.95 B | ||
|
Envista Holdings Corporation
NVST
|
39 M | $ 26.49 | -1.05 % | $ 4.45 B | ||
|
Pulse Biosciences
PLSE
|
1.57 M | $ 21.83 | -3.62 % | $ 1.47 B | ||
|
Retractable Technologies
RVP
|
286 K | $ 0.62 | -2.99 % | $ 18.6 M | ||
|
LeMaitre Vascular
LMAT
|
2.94 M | $ 112.4 | -1.85 % | $ 2.54 B | ||
|
STAAR Surgical Company
STAA
|
5.87 M | $ 26.7 | 0.07 % | $ 1.32 B | ||
|
STERIS plc
STE
|
34.2 M | $ 219.75 | -1.1 % | $ 21.7 B | ||
|
Predictive Oncology
POAI
|
654 K | - | - | $ 31.1 M | ||
|
Teleflex Incorporated
TFX
|
100 M | $ 135.52 | 0.33 % | $ 6.05 B | ||
|
BioLife Solutions
BLFS
|
1.51 M | $ 20.9 | -2.38 % | $ 963 M | ||
|
Stereotaxis
STXS
|
642 K | $ 1.86 | -3.63 % | $ 169 M | ||
|
Baxter International
BAX
|
81 M | $ 17.94 | -2.97 % | $ 9.2 B | ||
|
ResMed
RMD
|
21.9 M | $ 217.14 | -2.2 % | $ 31.7 B | ||
|
AtriCure
ATRC
|
1.73 M | $ 28.48 | -1.93 % | $ 1.36 B | ||
|
Utah Medical Products
UTMD
|
60 K | $ 66.61 | -0.25 % | $ 216 M | ||
|
Harvard Bioscience
HBIO
|
1.52 M | $ 6.45 | -5.56 % | $ 286 M | ||
|
NeuroMetrix
NURO
|
107 K | - | 5.05 % | $ 9.02 M | ||
|
West Pharmaceutical Services
WST
|
22.7 M | $ 292.13 | -3.33 % | $ 21.1 B | ||
|
DENTSPLY SIRONA
XRAY
|
47 M | $ 11.78 | -1.51 % | $ 2.35 B | ||
|
AngioDynamics
ANGO
|
1.84 M | $ 10.98 | -0.99 % | $ 449 M | ||
|
Becton, Dickinson and Company
BDX
|
135 M | $ 149.52 | -0.47 % | $ 43 B | ||
|
Nephros
NEPH
|
442 K | $ 3.32 | 2.79 % | $ 34.5 M | ||
|
OraSure Technologies
OSUR
|
2.16 M | $ 3.01 | - | $ 221 M | ||
|
Repligen Corporation
RGEN
|
5.63 M | $ 117.43 | -0.73 % | $ 6.54 M |